UCLA researchers are developing the first multiple sclerosis treatment that could target the cause of the disease, instead of simply treating its symptoms. Multiple sclerosis is an autoimmune disease in which the fatty coating of nerve cells, called the myelin sheath, is broken down by one’s immune system. Read more...
Photo: UCLA researchers are developing the first multiple sclerosis treatment that would target the disease’s cause rather than only treating its symptoms. The study found that its symptoms could be alleviated with estriol treatments. Rhonda Voskuhl, the director of the UCLA Multiple Sclerosis Program and Clinic, led the study. (Courtesy of UCLA Health)
